Signet Healthcare Partners provides growth capital to commercial stage healthcare companies around the world.
Pharmaceutical company active in Research & Development and Production of ODT (Orally Dispersible Tablet) products.
Apicore is a leading developer and manufacturer of technically complex active pharmaceutical ingredients (APIs).
A development company focused on cancer, infectious diseases and other immune disorders through the manipulation of dendritic cells.
An drug delivery company developing innovative technology for needle-free injection.
Developing and marketing hard-to-formulate generic drugs in the U.S.
A specialty pharmaceutical company that markets in-licensed hospital products in Taiwan and China.
Chr Olesen Synthesis A/S (COS) a contract developer and manufacturer of technically complex active pharmaceutical ingredients (“APIs”). Based in Copenhagen Denmark, the Company operates a facility capable of producing both clinical and commercial-scale quantities. COS is presently using its technical expertise in producing complex and highly potent molecules for generic drug companies.
CoreRx is a contract pharmaceutical development organization that helps get you into the clinic faster, providing a complete spectrum of cGMP solutions for pharmaceutical dosage form development.
Claris Lifesciences is one of the largest sterile injectables pharmaceutical companies in India with a market presence in 91 countries worldwide.
Tools and instruments company utilizing micro fluidic technology for cell based assays used in research, drug discovery and diagnostic applications.
A privately held company focused on the development and commercialization of novel ophthalmic pharmaceuticals, based on its proprietary drug delivery platform, Verisome®.
Based in Toronto, Canada, ImpoPharma, Inc. is a pharmaceutical company focused on the development of nasal and pulmonary products.
KEW is revolutionizing cancer care by empowering oncologists to access and apply genomic insights in order to design optimal, individualized treatment approaches for patients.
Headquartered in Munich, is a nanotechnology-based drug development company focused on reformulations and reinventions of drugs on a contract or co-development basis. The core business is the reformulations to develop novel oral and parenteral formulations and innovative drug combinations, which have not been possible in the past due to low bioavailability caused by low solubility of APIs.
Medical device company focused on glucose monitoring.
Pfenex is a protein expression company. Its proprietary platform technology accelerates the development of new biotherapeutics and vaccines. It also lowers production costs.
Sancilio and Company is a specialty pharmaceutical company developing and manufacturing medicines to treat cardiovascular disease and to promote women's health.
Pan-European specialty pharmaceutical company focused on oncology and palliative care drugs.
TELA Bio is a Malvern, PA based medtech company focused on soft tissue reconstruction.
Formulates manufactures and markets generic pharmaceuticals in the U.S.
A developer and manufacturer of generic pharmaceutical products in tablet, capsule, liquid and suppository dosage forms.
Develops and manufactures commercial and clinical APIs.
A neuroscience company focused on the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.
Specialized in the development, manufacturing and distribution of innovative injectable medical devices based on biopolymer transformation.
Arbor Pharmaceuticals is an Atlanta, GA based specialty pharmaceutical company which currently markets prescription products for cardiovascular and pediatric disorders.
Atlantis is a commercial stage medical device company engaged in the development, manufacture and sale of key components used in dental implants
Develops and commercializes specialty pharmaceutical products with significant advantages based on our innovative drug delivery technologies.
Generates and optimizes proteins and enzymes for industrial applications and biopharmaceuticals.
A pharmaceutical company focusing on the discovery, development, and commercialization of novel peptide-based drugs.
Contract and manufacturing product development to pharmaceutical and biotechnology companies for parenteral products. Acquired by Cangene Corporation.
A provider of technology-based products and services that enable the pharmaceutical, biotechnological, medical device, and contract resource companies to collect, interpret, and distribute cardiac safety and clinical data more efficiently.
A biopharmaceutical company utilizing its proprietary Random Homozygous Gene Perturbation (RHGP) technology to create new therapies and enhance industrial bioprocessing.
Creates and delivers web-based, multimedia training courses to regulated health and life sciences industries worldwide.
Indian based manufacturer of active pharmaceutical ingredients.
Specialty pharmaceutical company focused on developing and commercializing drugs for central nervous system (CNS) disorders.
A medical device company focused on improving surgery.
Medtronic is a medical device company that is committed to providing physicians with surgical tools that have the precision of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral damage – a revolutionary benefit that fills a critical market gap.
Develops, manufactures and markets a plasma based electrosurgical cutting tool.
Contract manufacturer of viral vaccines and therapeutics.
OctoPlus is a product-oriented drug delivery company focused on the development of improved pharmaceutical products with less side effects, increased patient compliance and better efficacy.
A specialty pharmaceutical company with products marked in the U.S. and Europe.
Designs, manufactures and markets wireless communication equipment consisting of land mobile radios ("LMR's") and base station components and systems.
Manufactures and markets intensity modulated radiation therapy (IMRT) equipment.
Develops and markets therapeutics for urology and endocrinology specialties.
Operates convenience stores in the New England area.
Signet Healthcare partners was founded in 1998 with the establishment of the Corporate Opportunities Funds. Since 1998, we have organized three funds and completed investments in approximately 35 companies. The team is comprised of six professionals with principal offices in New York City. This team brings over 100 years experience of collective healthcare experience in the specialty pharmaceutical, medical device, private equity and investment banking businesses.
For the past sixteen years, Signet Healthcare has maintained its dedicated focus to diversified healthcare investing – primarily serving as lead investor to expansion stage companies engaged in specialty pharmaceuticals, medical devices and the pharma services industries.
We seek investment opportunities in which we can play an active and substantial role in helping management perform to their full potential and create shareholder value. We are both minority and majority investors in companies which are close to, or have achieved commercial operations and are seeking expansion stage capital. In general, we target investment opportunities where we can capitalize on operational efficiencies and revenue expansion opportunities through business development activities and product strategies, including life cycle management.
Innovation, access to technical skills, lower production costs, and sales and marketing opportunities have created opportunities outside the U.S. Since inception of our Funds, we have invested on a global basis with approximately 20% of our funds committed to entities domiciled in Europe and Asia. In general, we invest internationally with strong local investment partners.